Clinical Trials Insight: 700024170
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2009
At a glance
- Drugs AVN 944 (Primary)
- Indications Autoimmune disorders; Haematological malignancies; Pancreatic cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Avalon Pharmaceuticals
- 01 Jan 2009 Status changed from active, no longer recruiting to completed.
- 01 Jan 2009 Results reported in the Journal of Clinical Pharmacololgy.
- 27 Jun 2007 New trial record.